Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShort-Term Debt repayments
Ratios

Palisade Bio (PALI) Accumulated Depreciation & Amortization (2016 - 2020)

Historic Accumulated Depreciation & Amortization for Palisade Bio (PALI) over the last 10 years, with Q4 2020 value amounting to $910956.0.

  • Palisade Bio's Accumulated Depreciation & Amortization fell 415.2% to $910956.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $910956.0, marking a year-over-year decrease of 415.2%. This contributed to the annual value of $910956.0 for FY2020, which is 415.2% down from last year.
  • Palisade Bio's Accumulated Depreciation & Amortization amounted to $910956.0 in Q4 2020, which was down 415.2% from $950417.0 recorded in Q4 2019.
  • Over the past 5 years, Palisade Bio's Accumulated Depreciation & Amortization peaked at $950417.0 during Q4 2019, and registered a low of $724771.0 during Q4 2016.
  • In the last 5 years, Palisade Bio's Accumulated Depreciation & Amortization had a median value of $902260.0 in 2018 and averaged $862065.8.
  • In the last 5 years, Palisade Bio's Accumulated Depreciation & Amortization soared by 1530.82% in 2016 and then tumbled by 415.2% in 2020.
  • Over the past 5 years, Palisade Bio's Accumulated Depreciation & Amortization (Quarter) stood at $724771.0 in 2016, then increased by 13.4% to $821925.0 in 2017, then rose by 9.77% to $902260.0 in 2018, then rose by 5.34% to $950417.0 in 2019, then fell by 4.15% to $910956.0 in 2020.
  • Its last three reported values are $910956.0 in Q4 2020, $950417.0 for Q4 2019, and $902260.0 during Q4 2018.